1Tylee A, Gastpar M, LepineJP, et al. DE PRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee[J] Int Clin Psychopharmacol, 1999,14: 139-151.
2McClintock SM, Husain MM, Wisniewski SR, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication[J].J Clin Psychopharmacol, 2011 ,31 : 180-186.
3Greco T, Eckert G, Kroenke K. The outcome of physical symptoms with treatment of depression[J].J Gen Intern Med, 2004,19:813-818.
4Judge R, PlewesJM, Kumar V, et al. Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials[J].J Clin Psychopharmacol, 2000 , 20 : 666-672.
5Fava M, Ball S, NelsonJC, et al. Clinical relevance of fatigue as a residual symptom in major depressive disorder[J/OL]. Depress Anxiety, 2013,30: 1-6[2013-11-IOJ. http://www. ncbi. nlm. nih. gov/pubmed/? term = CLINICAL + relevance + of + fatigue + as + a + residuaal + symptom + in + major + depressive + disorder.
